Literature DB >> 12198658

Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity.

Lars E Schmidt1, Kim Dalhoff.   

Abstract

Hypophosphatemia is frequently observed in acetaminophen-induced hepatotoxicity and may be involved in the pathogenesis of hepatic failure. The aim of the study was to evaluate the prognostic value of serial measurements of serum phosphate in patients with severe acetaminophen poisoning. Prospectively, serial measurements of serum phosphate were performed in 125 patients with severe acetaminophen poisoning. The optimum threshold value of serum phosphate to discriminate nonsurvivors was identified. Prognostic value and speed of identification were compared with those of the King's College Hospital (KCH) criteria. Phosphate concentrations were significantly higher in nonsurvivors than in survivors at 48 to 72 hours after overdose (mean 2.65 +/- 1.18 mmol/L vs. 0.68 +/- 0.22 mmol/L, P <.001) as well as 72 to 96 hours after overdose (2.12 +/- 0.22 mmol/L vs. 0.59 +/- 0.23 mmol/L, P <.001). A threshold phosphate concentration of 1.2 mmol/L at 48 to 96 hours after overdose had sensitivity 89%, specificity 100%, accuracy 98%, positive predictive value 100%, and negative predictive value 98%. The phosphate criteria had higher sensitivity, accuracy, and positive and negative predictive values than the KCH criteria, and it identified patients significantly earlier after transferal [median 1 hour (range 1-38 hours) vs. 12 hours (2-192 hours), P <.05, respectively]. In nonsurvivors, the degree of hyperphosphatemia correlated with renal dysfunction (R =.55; P =.02). In conclusion, hyperphosphatemia after acetaminophen overdose is seen exclusively in nonsurvivors, which makes it a highly specific as well as sensitive predictor of nonsurvival. We propose that hyperphosphatemia is caused by renal dysfunction in the absence of hepatic regeneration, as the latter appears to be associated with lowering of serum phosphate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198658     DOI: 10.1053/jhep.2002.35069

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

1.  Predicting daily outcomes in acetaminophen-induced acute liver failure patients with machine learning techniques.

Authors:  Jaime Lynn Speiser; Constantine J Karvellas; Bethany J Wolf; Dongjun Chung; David G Koch; Valerie L Durkalski
Journal:  Comput Methods Programs Biomed       Date:  2019-04-11       Impact factor: 5.428

Review 2.  Drug-Induced Hypophosphatemia: Current Insights.

Authors:  Efstathia Megapanou; Matilda Florentin; Haralampos Milionis; Moses Elisaf; George Liamis
Journal:  Drug Saf       Date:  2020-03       Impact factor: 5.606

3.  ACMT Position Statement: Duration of Intravenous Acetylcysteine Therapy Following Acetaminophen Overdose.

Authors: 
Journal:  J Med Toxicol       Date:  2016-03-08

Review 4.  Acute liver failure and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

5.  Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure.

Authors:  Constantine J Karvellas; Jaime L Speiser; Mélanie Tremblay; William M Lee; Christopher F Rose
Journal:  Hepatology       Date:  2017-01-19       Impact factor: 17.425

6.  Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography.

Authors:  R Todd Stravitz; Ton Lisman; Velimir A Luketic; Richard K Sterling; Puneet Puri; Michael Fuchs; Ashraf Ibrahim; William M Lee; Arun J Sanyal
Journal:  J Hepatol       Date:  2011-05-19       Impact factor: 25.083

7.  Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects.

Authors:  T T Knudsen; S Thorsen; S A Jensen; K Dalhoff; L E Schmidt; U Becker; F Bendtsen
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 8.  Etiology and management of fulminant hepatic failure.

Authors:  Javier Vaquero; Andres T Blei
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 9.  Acute liver failure.

Authors:  Ludwig Kramer
Journal:  Wien Klin Wochenschr       Date:  2004-02-16       Impact factor: 1.704

Review 10.  Hepatology - Guidelines on Parenteral Nutrition, Chapter 16.

Authors:  M Plauth; T Schuetz
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.